Viral Shedding and Transmission Potential of Asymptomatic and Paucisymptomatic Influenza Virus Infections in the Community

Background Influenza virus infections are associated with a wide spectrum of disease. However, few studies have investigated in detail the epidemiological and virological characteristics of asymptomatic and mild illness with influenza virus infections. Methods In a community-based study in Hong Kong from 2008 to 2014, we followed up initially healthy individuals who were household contacts of symptomatic persons with laboratory-confirmed influenza, to identify secondary infections. Information from daily symptom diaries was used to classify infections as symptomatic (≥2 signs/symptoms, including fever ≥37.8°C, headache, myalgia, cough, sore throat, runny nose and sputum), paucisymptomatic (1 symptom only), or asymptomatic (none of these symptoms). We compared the patterns of influenza viral shedding between these groups. Results We identified 235 virologically confirmed secondary cases of influenza virus infection in the household setting, including 31 (13%) paucisymptomatic and 25 (11%) asymptomatic cases. The duration of viral RNA shedding was shorter and declined more rapidly in paucisymptomatic and asymptomatic than in symptomatic cases. The mean levels of influenza viral RNA shedding in asymptomatic and paucisymptomatic cases were approximately 1-2 log10 copies lower than in symptomatic cases. Conclusions The presence of influenza viral shedding in patients with influenza who have very few or no symptoms reflects their potential for transmitting the virus to close contacts. These findings suggest that further research is needed to investigate the contribution of persons with asymptomatic or clinically mild influenza virus infections to influenza virus transmission in household, institutional, and community settings.

[1]  E. Lau,et al.  Increases in absenteeism among health care workers in Hong Kong during influenza epidemics, 2004–2009 , 2015, BMC Infectious Diseases.

[2]  P. Ward,et al.  Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis. , 2004, The Journal of infectious diseases.

[3]  C. King,et al.  Estimating pathogen-specific asymptomatic ratios. , 2010, Epidemiology.

[4]  J. Oxford,et al.  Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans , 2012, Nature Medicine.

[5]  Chin‐Yun Lee,et al.  Viral load and clinical features in children infected with seasonal influenza B in 2006/2007. , 2012, Journal of the Formosan Medical Association = Taiwan yi zhi.

[6]  B. Cowling,et al.  The Dynamic Relationship Between Clinical Symptomatology and Viral Shedding in Naturally Acquired Seasonal and Pandemic Influenza Virus Infections. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  P. Horby,et al.  Pandemic H1N1 virus transmission and shedding dynamics in index case households of a prospective Vietnamese cohort☆ , 2014, The Journal of infection.

[8]  Y. Guan,et al.  Children with Respiratory Disease Associated with Metapneumovirus in Hong Kong , 2003, Emerging infectious diseases.

[9]  J. Peiris,et al.  Association of Oseltamivir Treatment With Virus Shedding, Illness, and Household Transmission of Influenza Viruses. , 2015, The Journal of infectious diseases.

[10]  Anne M Johnson,et al.  Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study , 2014, The Lancet Respiratory Medicine.

[11]  P. Zhao,et al.  Detection of influenza B in clinical specimens: comparison of high throughput RT-PCR and culture confirmation. , 2004, Virus research.

[12]  Karen Ekernas,et al.  Facemasks and Hand Hygiene to Prevent Influenza Transmission in Households: A Cluster Randomized Trial , 2010 .

[13]  Benjamin J Cowling,et al.  Viral Shedding and Clinical Illness in Naturally Acquired Influenza Virus Infections , 2010, The Journal of infectious diseases.

[14]  Viral genetic sequence variations in pandemic H1N1/2009 and seasonal H3N2 influenza viruses within an individual, a household and a community. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[15]  T. R. Peters,et al.  Exposure to influenza virus aerosols during routine patient care. , 2013, The Journal of infectious diseases.

[16]  Benjamin J Cowling,et al.  Comparative epidemiology of pandemic and seasonal influenza A in households. , 2010, The New England journal of medicine.

[17]  Pardeep Singh,et al.  Longitudinal study of influenza molecular viral shedding in Hutterite communities. , 2012, The Journal of infectious diseases.

[18]  L. Mermel,et al.  Does Influenza Transmission Occur from Asymptomatic Infection or Prior to Symptom Onset? , 2009, Public health reports.

[19]  V. Knight,et al.  Human Influenza Resulting from Aerosol Inhalation , 1966, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[20]  Benjamin J. Cowling,et al.  Aerosol transmission is an important mode of influenza A virus spread , 2013, Nature Communications.

[21]  Benjamin J Cowling,et al.  Review Article: The Fraction of Influenza Virus Infections That Are Asymptomatic A Systematic Review and Meta-analysis , 2015, Epidemiology.

[22]  J. Peiris,et al.  Comparison of nasopharyngeal flocked swabs and aspirates for rapid diagnosis of respiratory viruses in children. , 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[23]  J. Peiris,et al.  Influenza A Virus Shedding and Infectivity in Households. , 2015, The Journal of infectious diseases.

[24]  N. Ferguson,et al.  Time lines of infection and disease in human influenza: a review of volunteer challenge studies. , 2008, American journal of epidemiology.

[25]  U. Buchholz,et al.  Comparison of Shedding Characteristics of Seasonal Influenza Virus (Sub)Types and Influenza A(H1N1)pdm09; Germany, 2007–2011 , 2012, PloS one.